Nano-formulation of darkness hormone could be therapeutic solution for Parkinson's disease
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
The President said that there is a need to spread more and more awareness regarding the causes, diagnosis and treatment of cancer
Innovent has granted Roche exclusive global rights to develop, manufacture and commercialize IBI3009
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
Final decision from the European Commission is anticipated within the coming months
First and only PARP inhibitor to improve overall survival in early breast cancer
Based on data, 1.75 mg/kg dose established as recommended dose for Phase 3 trial of this investigational antibody-drug conjugate
Patients treated with Polivy in combination with R-CHP required fewer subsequent treatments, potentially reducing burdens on patients and healthcare systems
For people with relapsed or refractory diffuse large B-cell lymphoma
Subscribe To Our Newsletter & Stay Updated